CD8A and neoplasm: Finally we show that TERS-imprinted myeloid DC co-injected with tumor cells into naïve immunocompetent mice promote tumor take, accelerate tumor growth, and decrease the number of CD8+ tumor-infiltrating lymphocytes, even promoting transient outgrowth of immunogenic tumor cells.